ROBERT SHEPHERD: Open Payments
NPI 1205995438 · SHREWSBURY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$935 in 45 payments from 12 companies in 2025. Trend: 2023 $696 · 2024 $828 · 2025 $935
Food & beverage: $935
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 10 | $183 |
| Exact Sciences Corporation | 6 | $139 |
| Lilly USA, LLC | 7 | $131 |
| Lundbeck LLC | 4 | $94 |
| Otsuka America Pharmaceutical, Inc. | 4 | $87 |
| Aimmune Therapeutics, Inc. | 3 | $68 |
| PFIZER INC. | 3 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| Ardelyx, Inc. | 2 | $50 |
| Abbott Laboratories | 1 | $21 |
Products named: SPRAVATO, REXULTI, Cologuard Collection Kit, JARDIANCE, NURTEC ODT, XIFAXAN, IBSRELA, VOWST.
Industry payments across MA — which companies pay providers there.
